Kessler Foundation, Inc.

Kessler Foundation, Inc., a non-profit rehabilitation research organization based in East Hanover, New Jersey, operates as a federal grant recipient (75% of recent awards) and subcontractor conducting biomedical and health services research in neurological rehabilitation, disability outcomes, and employment intervention. The foundation does not hold federal contracts as a prime contractor; its footprint consists almost entirely of federal grants and grant sub-awards from health, disability, and veterans agencies, with three small Department of Veterans Affairs purchase orders for biomarker development and research psychology services totaling roughly $75,000.

The foundation's primary customer concentration reflects its research mission. The Department of Health and Human Services Administration for Community Living (26 awards) and the Office of Special Education and Rehabilitative Services (15 awards) lead by award count, accounting for 41 of 77 identified grant awards. The Defense Health Agency (15 awards) and the National Institute of Child Health and Human Development (11 awards) follow. These five customer agencies represent 61% of all awards. By dollar magnitude, the Veterans Health Administration's Veterans Integrated Service Network 2 carries $308,000 in potential value across nine awards, and the CDC's Cincinnati office carries $168,000 across a single award; combined potential value across all 127 awards stands at $569,000, though obligated dollars ($152.8 million) far exceed potential value, indicating that grants are fully or substantially obligated upon award. This gap reflects the grant-funding model: potential value often reflects the ceiling or authorized amount, while obligated dollars represent actual fund allocations.

Recent grant work anchors the foundation's capability portfolio. NICHD-funded grants (CFDA 93.865) include a $281,114 project grant awarded June 1, 2026, investigating transcutaneous spinal cord stimulation for blood pressure regulation and orthostatic hypotension in spinal cord injury (completion May 31, 2028), and a $327,808 K23 Career Development Award (CFDA 93.865) awarded August 7, 2025, advancing physical activity promotion and health outcomes in transition-age youth on the autism spectrum (completion July 31, 2030). The Defense Health Agency (CFDA 12.420, Military Medical Research and Development) funds three active grants totaling over $7 million: a $3.998 million four-year investigation into powered wearable orthotics for spinal cord injury function (September 1, 2023 to August 31, 2027), a $2.727 million personalized cognitive-motor virtual reality intervention for gait and balance improvement (September 30, 2024 to September 29, 2028), and a grant for transcutaneous spinal stimulation and gait training in traumatic brain injury (September 1, 2024 to August 31, 2028). The National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR) funds the Northern New Jersey Traumatic Brain Injury Model System (continuation grant, September 1, 2022 to August 31, 2027), the Northern New Jersey Spinal Cord Injury System (September 1, 2021 to August 31, 2026), and a rehabilitation technology research center on advancing robotics and neuromodulation for lower-extremity rehabilitation (September 1, 2024 to August 31, 2029). The National Institute of Standards and Technology Congressionally-Identified Projects program (CFDA 11.617) awarded $963,000 for MRI scanner upgrades at Kessler's Rocco Ortenzio Neuroimaging Center (October 1, 2024 to September 30, 2025). The National Institute on Aging (CFDA 93.866) funds a multi-site randomized clinical trial on the Kessler Foundation Modified Story Memory Technique for mild cognitive impairment (August 15, 2022 to November 30, 2027).

Activity has grown substantially: six awards in 2022, ten in 2023, eighteen in 2024, nine in 2025, and three in 2026 year-to-date. Awards reaching ultimate completion in the next twenty-four months total fifteen with a combined potential value of $10,000, representing minimal recompete exposure given the foundation's grant-dependent model and the multi-year award cycle typical of NIH and NIDILRR funding. The foundation subcontracts as a research partner to leading academic and healthcare institutions. Recent sub-awards place Kessler as a data collection, recruitment, and site-coordination partner under prime grants from Icahn School of Medicine at Mount Sinai (ENRICH Brain Health Project, two sub-awards in 2025–2026 for TBI model systems subject recruitment and data collection), Rutgers University (evidence-based modeling for dyslexia treatment, October 2025), The Ohio State University (multi-site TBI rehabilitation therapy standardization, October 2025), the University of Delaware (spinal cord injury outcomes research with cross-sectional and longitudinal data collection, October–December 2024), and the University System of New Hampshire (physical activity and employment intervention projects, multiple sub-awards 2024–2025). Kessler also receives sub-awards from the New Jersey Department of Labor and Workforce Development for vocational rehabilitation services to spinal cord injury and brain injury patients (January 2026 and November 2024 renewals).

The foundation's research portfolio concentrates on rehabilitation and disability outcomes across traumatic brain injury, spinal cord injury, stroke, multiple sclerosis, autism spectrum disorder, and mild cognitive impairment. Work spans neuroimaging infrastructure, cognitive rehabilitation protocol development, virtual reality and robotic-assisted interventions, employment readiness tools, and epidemiological surveillance through model systems databases. Kessler competes exclusively in the full-and-open federal grants marketplace, with no set-aside designations. Awards show no characteristic set-aside posture; all listed contract and grant awards carry "No Set-Aside Used" or equivalent designations. The foundation operates as a research institution leveraging federal grant and cooperative agreement mechanisms rather than as a federal contractor, positioning itself in the NIH, NIDILRR, and VA research funding ecosystems rather than in procurement vehicles such as GWACs or GSA schedules.